BETISTINE 16 MG

Negara: Israel

Bahasa: Inggris

Sumber: Ministry of Health

Bahan aktif:

BETAHISTINE HYDROCHLORIDE

Tersedia dari:

RAFA LABORATORIES LTD

Kode ATC:

N07CA01

Bentuk farmasi:

TABLETS

Komposisi:

BETAHISTINE HYDROCHLORIDE 16 MG

Rute administrasi :

PER OS

Jenis Resep:

Required

Diproduksi oleh:

RAFA LABORATORIES LTD, JERUSALEM

Kelompok Terapi:

BETAHISTINE

Area terapi:

BETAHISTINE

Indikasi Terapi:

Meniere`s syndrome. Symptomatic treatment of peripheral vertigo.

Tanggal Otorisasi:

2020-11-30

Selebaran informasi

1
PATIENT LEAFLET ACCORDING TO THE PHARMACISTS' REGULATIONS
(PREPARATIONS) – 1986
This medicine is sold with a doctor's prescription only.
BETISTINE 16 MG
TABLETS
ACTIVE INGREDIENT:
EACH TABLET CONTAINS: 16 mg of betahistine hydrochloride.
For the list of the additional ingredients, see section 6. See also
'Important information about
some of the medicine's ingredients' in section 2.
READ THIS ENTIRE LEAFLET CAREFULLY BEFORE USING THE MEDICINE. This
leaflet contains concise
information about the medicine. If you have any further questions,
please refer to your doctor
or pharmacist.
This medicine has been prescribed for your treatment. Do not pass it
on to others. It may harm
them, even if it seems to you that their medical condition is similar
to yours.
1. WHAT IS THE MEDICINE INTENDED FOR?
For treatment of Ménière's syndrome.
For treatment of peripheral vertigo.
THERAPEUTIC GROUP: anti-vertigo medicines.
The medicine contains betahistine which is a histamine analog used for
treatment of Ménière's
syndrome symptoms, which include: dizziness (vertigo), ringing in the
ears (tinnitus), hearing
loss, hearing difficulties.
The medicine acts by improving the blood flow in the inner ear,
thereby reducing pressure
buildup.
2. BEFORE USING THE MEDICINE
DO NOT USE THE MEDICINE IF:
•
You are sensitive (allergic) to the active ingredient (betahistine) or
to any of the other ingredients
the medicine contains (for the list of the additional ingredients, see
section 6).
•
You suffer from a tumor in the adrenal gland (pheochromocytoma).
SPECIAL WARNINGS REGARDING THE USE OF THIS MEDICINE:
BEFORE (AND DURING) TREATMENT WITH BETISTINE, INFORM YOUR DOCTOR IF:
•
You suffer from asthma (your doctor may wish to monitor your asthma
condition during the
treatment).
•
You suffer or have suffered in the past from a stomach ulcer.
•
You are pregnant, think you are pregnant or planning a pregnancy.
•
You are breastfeeding.
If one of the conditions described above is relevant to you, your
doctor will advise you whether you